Sharma R K, Jha R, Kumar P, Kher V, Gupta A, Kumar A, Gulati S, Arora P, Murari M, Bhandari M
Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Am J Nephrol. 1996;16(4):358-60. doi: 10.1159/000169024.
Visceral leishmaniasis is infrequently reported in renal transplant recipients. A 40-year-old renal transplant recipient developed hepatosplenomegaly and pyrexia of unknown origin 5 months after transplantation. Visceral leishmaniasis was confirmed on bone marrow examination. The usual dose of antiparasitic therapy with stibogluconate sodium failed to eradicate Leishmania donovani. High-dose conventional therapy with stibogluconate sodium for an extended period of time was successful in the treatment of a relapse of leishmaniasis.
内脏利什曼病在肾移植受者中鲜有报道。一名40岁的肾移植受者在移植后5个月出现肝脾肿大和不明原因发热。骨髓检查确诊为内脏利什曼病。常规剂量的葡萄糖酸锑钠抗寄生虫治疗未能根除杜氏利什曼原虫。大剂量葡萄糖酸锑钠常规治疗较长时间成功治愈了利什曼病复发。
